| Home > News/Research Updates
Don't miss out... click the tab at left to register for e-Notifications of when the next News/Research Updates are posted here.
The pain management field is rapidly changing. Pain Treatment Topics associates continuously scan news media, medical journals, and other information resources for News & Research of interest and importance to the field. Generally, items included in these Updates are selected on the basis of their relevance for everyday clinical practice in the management of pain and their support by scientific evidence.
All facts and opinions are those of the sources cited, unless otherwise specified. News/Research items have been edited for length and/or modified for clarity without altering essential data as originally published. Pain Treatment Topics and its associates do not endorse any medications, products, services, or treatments mentioned in any of these News/Research Update items or the referenced sources. Also see the Disclaimer at the end of these Updates.
Pain Treatment News/Research Updates Issues...
A Bonus of Opioid Therapy: Psychotherapeutic Effects
IV Morphine Titration Relieves Acute Pain in the ED
Guidelines for Parental Methadone in Palliative Care
Rotation From Other Opioids to Methadone Reviewed
Transdermal Buprenorphine Favorably Reviewed
Whiplash Injury Trigger Points Identified
Improved Coping Skills Help Headache Sufferers
Taken Early, Sumatriptan/Naproxen Relieves Migraine Pain
Unexplained Chest/Epigastric Pain Could Signal Heart Disease
PTSD May Hinder Pain Relief
Yoga Helps Improve Low Back Pain, Flexibility
Drug Combo Increases Remission in Early RA
Pot Provides Neuropathic Pain Relief, Study Says
Vitamin D for Chronic Pain: PPM Journal
Recent Drug or Device Approvals and Announcements
oxycodone ER, hydromorphone, buprenorphine, duloxetine, lubiprostone
<Back to Top>
Vitamin D for Relieving Chronic Pain Examined
Methylnaltrexone Relieves Opioid-Induced Constipation
Frequent Opioid Use May Increase Risk of Chronic Migraine
Transdermal Fentanyl Provides Osteoarthritis Pain Relief
Opioid Pain-Relief Benefits Outweigh Risks of Abuse
Deep Heat and Exercise Improve Frozen Shoulder
Recent Research Recommends Tai Chi for Arthritis
Associations of Daily Chronic Pain & Diabetes Studied
Local Infiltration Analgesia For Postoperative Knee Pain
SPINE Supplement Devoted to Neck Pain Research
Pregabalin Offers Long-Term Relief of Painful Neuropathy
Duloxetine Effective for OA Knee Pain; Research Report
Gender Biases in Cancer-Pain Relief Found
Headache Sufferers May Need Evaluation for TMD
What is Consumer Reports Telling Patients About Opioids?
Recent Drug or Device Approvals and Announcements
Relistor, Treximet, morphine sulfate, TNF blockers, Amitiza, Orencia
<Back to Top>
Glucosamine Unhelpful for Hip Osteoarthritis
Injury-Related Pain Can Persist for a Year
New AHA Guidelines For Cocaine-Related Chest Pain
Pregabalin May Reduce Refractory Neuropathic Pain
Pediatric Trauma: Prehospital Pain Interventions Lacking
Buprenorphine Overdose in Young Children Reviewed
Celecoxib Improves Postop Recovery
Oxcarbazepine Ineffective in Preventing Migraine
Edema Associated with Methadone Therapy
Cod Liver Oil May Offer NSAID-Sparing Benefits in RA
Back & Neck Pain Costs, Disability Rising
CRPS Incidence in Patients With Multiple Sclerosis
Recent Drug or Device Approvals and Announcements
“Do Not Crush List” updated, etanercept, Tussionex, duloxetine, oxymorphone ER
<Back to Top>
Pain in the ER: Opioids Prescribed Less to Minority Patients
New Survey Finds Lots of Pain, Much of it Untreated
Long-Term Opioids in Chronic Noncancer Pain Reviewed
Strength Training of Neck Muscles Relieves Chronic Pain
Therapeutic Methadone Doses & Cardiac-Related Death
Psychotropic Drugs & False-Positive Methadone Screens
Constipation a Common Cause of Pediatric Abdominal Pain
Massage Therapy Reduces Postoperative Pain
Patients on Multiple NSAIDs May Have Poorer Quality of Life
Chronic Pain Can Disrupt Brain Function
Depression-Associated Pain Improved With Duloxetine
Sickle Cell Pain Higher Than Previously Estimated
Experiment Explores Opioid Tolerance
Recent Drug or Device Approvals and Announcements
natalizumab, bisphosphonates, diclofenac (patch), fentanyl (patch), antiepileptic drugs, colchicine, varenicline, botulinum toxin (types A/B)
<Back to Top>
| Disclaimer |
All URL links in this document were valid at the time of publication; however, the Internet is constantly changing and some linked sites may move or become inactive with time. All facts and opinions are those of the sources cited, unless otherwise specified. News and research items have been edited for length and/or modified for clarity without altering essential data as originally published.
Pain Treatment Topics and its associates do not endorse any medications, products, services, or treatments described, mentioned, or discussed in any of the sources referenced. Nor are any representations made concerning efficacy, appropriateness, or suitability of any such medications, products, services, or treatments. Product brand names, where noted, are for informational purposes only and are registered trademarks of their respective manufacturers.
In view of the possibility of human error or advances in medical knowledge, Pain Treatment Topics and its associates do not warrant the information contained in the above News/Research Updates is in every respect accurate or complete, and they are not responsible nor liable for any errors or omissions made by the original sources or for results obtained from the use of this information. If there are questions or needs for further information, readers are advised to consult the reference sources cited. |
|
Pain-Topics.org is supported by an educational grant from...







Addiction Treatment
Forum

American Academy
of Pain Management

American Association
for the Treatment of
Opioid Dependence

American College
of Hospice & Pain
Pharmacy

American Pain
Foundation

European Opiate
Addiction Treatment
Association

National Fibromyalgia
Association

Trigeminal Neuralgia
Association
|